Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness...
industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(30)
•••
Stevemin
X
View Profile
View Bullboard History
Post by
Stevemin
on Mar 05, 2021 2:40pm
Straight from Inmed's SEC filing today
KPMG LLP PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Canada Telephone (604) 691-3000 Fax (604) 691-3031 Consent of Independent Registered Public Accounting
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Mar 04, 2021 7:25am
Research
https://www.marijuanamoment.net/senate-marijuana-report-highlights-legalizations-popularity-and-risks-while-criticizing-dea-research-barriers/
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Mar 02, 2021 7:17am
Research Studies by Indication
https://www.cb1cap.com/researchailment
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 27, 2021 7:58am
Cannabinoid Pharma Future
This table shows the rigor involved with GMP pharma processes compared to other cannabis categories. Cannabis 3.0 is not be underestimated: https://www.inmedpharma.com/learn/gmp-manufacturing
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 25, 2021 3:12pm
Cannabis 3.0 happening
https://ca.finance.yahoo.com/news/biotech-firms-sound-cannabis-stocks-185713486.html
(5)
•••
blackgold909
X
View Profile
View Bullboard History
Post by
blackgold909
on Feb 23, 2021 12:06pm
US$29 Target Price
Following the safety and tolerability data from the two Phase I trials in healthy volunteers, INM-755 is moving forward into a Phase II (755-201-EB) trial in up to 20 epidermolysis bullosa (EB
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 21, 2021 11:26pm
Short Shares
No shares available to short. May as well go up from here. https://www.shortablestocks.com/?INM
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 20, 2021 2:25pm
Cannabis 3.0 Convo
https://mobile.twitter.com/todd_harrison?prefetchtimestamp=1613847640163
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 16, 2021 7:23pm
Rare Cannabinoids Investing
https://cannabisindustryjournal.com/column/how-rare-cannabinoids-will-impact-investing/
(28)
•••
kijiji
X
View Profile
View Bullboard History
Post by
kijiji
on Feb 16, 2021 6:01pm
US$4.5 Million Private Placement
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 14, 2021 9:11am
Biggest Wave is Here
This is really the beginning of the third wave for Cannabinoid Medicine and for Cannabis stocks in general. The gigantic US market will drive this wave and the pharma wave is expected to last up to 10
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Feb 12, 2021 1:42pm
RE:RE:RE:Momentum
https://mobile.twitter.com/jimcramer/status/1359987792491741184
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Feb 12, 2021 1:38pm
RE:RE:Momentum
Technicals and investment capital. For example, JW Asset Mgt has placed 80% of their 2.2B funds into the whole cannabis space. See response to Jim Cramer Twitter by JW Asset Mgt (Jason
...more
(35)
•••
gainwidpatience
X
View Profile
View Bullboard History
Comment by
gainwidpatience
on Feb 12, 2021 12:39pm
RE:Momentum
Technicals showing strong buy.. I doubled it up on US side! Let's see what happens!
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 12, 2021 11:45am
Momentum
InMed is likely going to $10 at this point. Fact is InMed a company that does things right instead of right now. Toxicology studies take a significant amount of time and effort and companies like
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company